Domov › Melanom › North Carolina › Durham
Klinične študije za Melanom v Durham, NC
21 študij za Melanom išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Vključevanje udeležencevFaza 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Durham
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Vključevanje udeležencevFaza 3
- Duke Health System, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Vključevanje udeležencevFaza 2
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Vključevanje udeležencevOpazovalna študija
- UNC- Chapel Hill, Chapel Hill · 10 mi stran
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Vključevanje udeležencevFaza 1/2
- University of North Carolina, Chapel Hill · 10 mi stran
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Vključevanje udeležencevFaza 1/2
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Vključevanje udeležencevFaza 1
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Vključevanje udeležencevFaza 1/2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Vključevanje udeležencevFaza 1/2
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
Vključevanje udeležencevFaza 1
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Vključevanje udeležencevFaza 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Vključevanje udeležencevFaza 2/3
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Vključevanje udeležencevFaza 3
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi stran
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Vključevanje udeležencev
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Vključevanje udeležencev
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13 mi stran
Študije za Melanom v drugih mestih
- Houston, TX59 študij
- New York City, NY38 študij
- Los Angeles, CA34 študij
- Nashville, TN33 študij
- Pittsburgh, PA31 študij
- Boston, MA26 študij
- Philadelphia, PA23 študij
- San Francisco, CA22 študij
- Atlanta, GA21 študij
- St. Louis, MO21 študij
- Columbus, OH21 študij
- Salt Lake City, UT21 študij
Druge študije v Durham
- Rak dojke63 študij
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Metastatski rak33 študij
- Akutna mieločna levkemija33 študij
- Rak pljuč32 študij
- Rak prostate32 študij
- Kolorektalni rak28 študij
- Kronična limfocitna levkemija27 študij
- Rak jajčnikov27 študij
- Srčno popuščanje26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.